The Neuromodulation Lab strives to help patients and participants succeed by researching non-invasive mental health technology that will help improve symptoms of dysphoria caused by depression, anxiety, PTSD and pain. Our studies primarily focus on the use of transcranial magnetic stimulation (TMS) and virtual reality (VR) as novel therapies for dysphoria. If you would like to learn more about TMS and VR therapies, please visit our Education section. 

Dr. F. Andrew Kozel is a tenured professor in the Florida State University College of Medicine as the Mina Jo Powell Endowed Chair in Neurological Sciences. He is the Director of FSU Neuromodulation. His research uses brain imaging and brain stimulation to better understand and treat neuropsychiatric disorders with the focus of improving the lives of patients with these devastating disorders.

Dr. Johnson is the Co-Director of FSU Neuromodulation and Research Faculty member of the FSU College of Medicine, Department of Behavioral Sciences and Social Medicine. His overall career goal is to translate neuroscience and behavioral research into useful therapies. He has worked in areas of non-invasive brain stimulation, neuroimaging, sensory testing and consumer health technology; with applications to mood disorders and pain. Current areas of research include improving access to neuromodulation therapies for mood disorders and pain, through novel stimulation protocols and simple sensory interventions.

Follow us on social media!

Clinical Treatment:

FSU Neuromodulation currently offers clinical Transcranial Magnetic Stimulation for the treatment of Major Depressive Disorder. Please visit the TMS Clinic website to learn more.

Educational Opportunities:

There are currently no open positions in the lab. If you have a research interest that you would like to discuss, please contact Dr. Johnson at kevin.a.johnson@med.fsu.edu.